Aberdeen Group
GH icon

Aberdeen Group’s Guardant Health GH Stock Holding History

Aberdeen Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-90,124
Closed -$8.32M – 953
2026
Q1 		$8.32M Buy
90,124
+15,000
+20% +$1.51M 0.01% 619
2025
Q4 		$7.67M Sell
75,124
-40,577
-35% -$3.63M 0.01% 652
2025
Q3 		$7.23M Sell
115,701
-57,560
-33% -$3.13M 0.01% 655
2025
Q2 		$9.02M Sell
173,261
-79,702
-32% -$3.56M 0.02% 619
2025
Q1 		$10.8M Sell
252,963
-189,988
-43% -$8.2M 0.02% 546
2024
Q4 		$13.5M Sell
442,951
-109,522
-20% -$3.08M 0.03% 448
2024
Q3 		$12.7M Buy
552,473
+178,882
+48% +$5.06M 0.02% 470
2024
Q2 		$10.8M Sell
373,591
-84,200
-18% -$1.96M 0.02% 499
2024
Q1 		$9.44M Buy
457,791
+111,707
+32% +$2.39M 0.02% 561
2023
Q4 		$9.36M Buy
+346,084
New +$9.08M 0.02% 562

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Aberdeen Group's GH Position: Q2 2026 in Review

Aberdeen Group sold out of Guardant Health (GH) in Q2 2026, closing a stake of 90,124 shares — an estimated $8.32M sold.

Aberdeen Group first reported a position in GH in Q4 2023 and held it in 10 quarters. The position peaked at $13.5M in Q4 2024. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Aberdeen Group reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
  • Aberdeen Group sold 90,124 Guardant Health shares in Q2 2026, an estimated $8.32M.
  • Aberdeen Group first reported a position in Guardant Health in Q4 2023 and held it in 10 quarters.
  • Aberdeen Group's Guardant Health position peaked at $13.5M in Q4 2024.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.